Evaluating anticancer activity of emodin by enhancing antioxidant activities and affecting PKC/ADAMTS4 pathway in thioacetamide-induced hepatocellular carcinoma in rats

Emodin is a naturally occurring anthraquinone derivative with a wide range of pharmacological activities, including neuroprotective and anti-inflammatory activities. We aim to assess the anticancer activity of emodin against hepatocellular carcinoma (HCC) in rat models using the proliferation, invas...

Full description

Saved in:
Bibliographic Details
Main Authors: Hanan M. Hassan (Author), Ahmed M. Hamdan (Author), Abdullah Alattar (Author), Reem Alshaman (Author), Omar Bahattab (Author), Mohammed M. H. Al-Gayyar (Author)
Format: Book
Published: Taylor & Francis Group, 2024-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8ad333485c1a416587f4d2f5edf12c6a
042 |a dc 
100 1 0 |a Hanan M. Hassan  |e author 
700 1 0 |a Ahmed M. Hamdan  |e author 
700 1 0 |a Abdullah Alattar  |e author 
700 1 0 |a Reem Alshaman  |e author 
700 1 0 |a Omar Bahattab  |e author 
700 1 0 |a Mohammed M. H. Al-Gayyar  |e author 
245 0 0 |a Evaluating anticancer activity of emodin by enhancing antioxidant activities and affecting PKC/ADAMTS4 pathway in thioacetamide-induced hepatocellular carcinoma in rats 
260 |b Taylor & Francis Group,   |c 2024-12-01T00:00:00Z. 
500 |a 10.1080/13510002.2024.2365590 
500 |a 1743-2928 
500 |a 1351-0002 
520 |a Emodin is a naturally occurring anthraquinone derivative with a wide range of pharmacological activities, including neuroprotective and anti-inflammatory activities. We aim to assess the anticancer activity of emodin against hepatocellular carcinoma (HCC) in rat models using the proliferation, invasion, and angiogenesis biomarkers. After induction of HCC, assessment of the liver impairment and the histopathology of liver sections were investigated. Hepatic expression of both mRNA and protein of the oxidative stress biomarkers, HO-1, Nrf2; the mitogenic activation biomarkers, ERK5, PKCδ; the tissue destruction biomarker, ADAMTS4; the tissue homeostasis biomarker, aggregan; the cellular fibrinolytic biomarker, MMP3; and of the cellular angiogenesis biomarker, VEGF were measured. Emodin increased the survival percentage and reduced the number of hepatic nodules compared to the HCC group. Besides, emodin reduced the elevated expression of both mRNA and proteins of all PKC, ERK5, ADAMTS4, MMP3, and VEGF compared with the HCC group. On the other hand, emodin increased the expression of mRNA and proteins of Nrf2, HO-1, and aggrecan compared with the HCC group. Therefore, emodin is a promising anticancer agent against HCC preventing the cancer prognosis and infiltration. It works through many mechanisms of action, such as blocking oxidative stress, proliferation, invasion, and angiogenesis. 
546 |a EN 
690 |a ADAMTS4 
690 |a Aggrecan 
690 |a Angiogenesis 
690 |a emodin 
690 |a hepatocellular carcinoma 
690 |a PKCδ 
690 |a Pathology 
690 |a RB1-214 
690 |a Biology (General) 
690 |a QH301-705.5 
655 7 |a article  |2 local 
786 0 |n Redox Report, Vol 29, Iss 1 (2024) 
787 0 |n https://www.tandfonline.com/doi/10.1080/13510002.2024.2365590 
787 0 |n https://doaj.org/toc/1351-0002 
787 0 |n https://doaj.org/toc/1743-2928 
856 4 1 |u https://doaj.org/article/8ad333485c1a416587f4d2f5edf12c6a  |z Connect to this object online.